Exemestane: an alternative treatment option in early breast cancer. Foreward.
Jassem
Jacek
J
Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.
D000730:Androstadienes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017698:Postmenopause
D000730:Androstadienes; D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; C056516:exemestane